Comparing The Safety And Efficacy Of Sitagliptin Vs Dapagliflozin And The Risk Of Hyperkalaemia Among People With Type 2 Diabetes Mellitus And Kidney Disease . VER [Internet]. 2025 Nov. 14 [cited 2026 Aug. 28];8(9s):230-6. Available from: https://verjournal.com/index.php/ver/article/view/745